RÉSUMÉ
Background: Law enforcement physical fitness training is not standardized in the United States; instead, there is heavy reliance on training officers or other LEOs with an interest in exercise. This study aimed to evaluate performance outcomes between a traditionally designed physical conditioning program and an evidence-based conditioning program for law enforcement cadets. Methods: Two metropolitan state law enforcement training centers in the southeast United States volunteered to participate in this investigation. Each program lasted 12 weeks and consisted of 5 days/week of physical training. The experimental group (n=46) was provided with an evidence-based physical conditioning program consisting of anaerobic and aerobic conditioning, agility, power, movement quality, defensive tactics, and muscular endurance. Results: The control group participants (n=18) were assigned to a traditional instructor-led physical training program consisting of calisthenics and running. Of the 14 fitness variables measured, the intervention group displayed improvements in 10 variables, whereas the control group improved 6 variables. Conclusions: The results of this study encourage law enforcement departments to make provisions for modifications to enhance traditional cadet physical training programs, with consultation from strength and conditioning subject matter experts.
RÉSUMÉ
@#<p style="text-align: justify;"><strong>Objective:</strong> Antenatal steroids have shown to decrease the rate of neonatal complications and morbidity; however, neonates are predisposed to significant hypoglycemia resulting in invasive interventions and prolonged nursery admissions. The risk of hypoglycemia in the preterm has been well studied, but the association of antenatal steroids and hypoglycemia in preterm neonates has not been well explored. Thus, we sought to determine the association of antenatal steroids given to mothers who delivered prematurely and the development of neonatal hypoglycemia.</p><p style="text-align: justify;"><strong>Methods:</strong> A cross-sectional study using chart review was done on mother-preterm neonate pairs admitted in the charity obstetrical ward of The University of Santo Tomas Hospital from January 1, 2018 to December 31, 2019. The subjects were mothers either given or not given antenatal steroids before preterm delivery and their respective neonates. The provision of antenatal steroids was the primary exposure, while neonatal hypoglycemia was the primary outcome. Measurement of association was done using odds ratios. Univariate and multivariate logistic regression analyses were done.</p><p style="text-align: justify;"><strong>Results:</strong> Of the 69 preterm neonates included in the study, hypoglycemia was observed in 14 neonates, among which 8 neonates were exposed to antenatal steroids. After examining the association using Fisher's exact formula and controlling for potential confounders, neonatal hypoglycemia was not significantly higher among neonates exposed to antenatal steroids.</p><p style="text-align: justify;"><strong>Conclusion:</strong> Antenatal steroids given to mothers who delivered preterm were not associated with the development of neonatal hypoglycemia. A prospective study model, larger population size and longer study coverage should be made to strengthen the outcome of the study.</p>
RÉSUMÉ
Outbreaks of acute gastroenteritis are a public health problem. Norovirus is known as the most common cause (50%). In Chile, immediate notification allows surveillance of these events. We describe an acute gastroenteritis outbreak that occurred in Antofagasta region, between March and April 2010. An observational study was conducted to perform the outbreak investigation. Local residents who met case definition were included. Stool samples, epidemiological surveys and environmental samples were requested. The outbreak began approximately on March 8, 2010 and lasted until April 28 with 31,036 reported cases (rate 54 per 1000 inhabitants). The most affected age group was between 25 and 44 years, and diarrhea was the main symptom (97% of cases). We determined the presence of norovirus genogroup II in clinical and environmental samples. This outbreak was caused by consumption of raw vegetables from La Chimba, which were watered and contaminated with treated sewage containing low concentration of free residual chlorine. Subsequently, the outbreak spread from person to person in a poor sanitary environment.
Antecedentes: Los brotes por gastroenteritis aguda constituyen un problema de salud pública. Se conoce al norovirus como la causa más común (50%). En Chile, la vigilancia de estos eventos, se establece mediante la notificación inmediata. Objetivo: Investigar y caracterizar el brote de gastroenteritis aguda ocurrido en la Región de Antofagasta, durante los meses de marzo y abril de 2010. Método: Se efectuó un estudio observacional descriptivo para realizar la investigación de brote. Se incluyó a residentes de la región que cumplían con la definición de caso. Se solicitó muestras de deposición, encuesta epidemiológica y muestras ambientales. Resultados: Se estimó que el brote comenzó el 8 de marzo de 2010 y duró hasta el 28 de abril del mismo año; se notificaron 31. 036 casos (tasa 54 por 1.000 habitantes). El grupo de 25 y 44 años de edad fue el más afectado y la diarrea fue el síntoma predominante (97% de los casos). Se determinó la presencia de norovirus genogrupo II en muestras clínicas y ambientales. Conclusiones: El brote se originó por el consumo crudo de hortalizas que provenían del sector La Chimba, las que fueron regadas y contaminadas con agua servida tratada que contenía baja concentración de cloro libre residual y posteriormente se propagó por transmisión persona-persona, en un ambiente sanitario deficiente.
Sujet(s)
Adolescent , Adulte , Enfant d'âge préscolaire , Femelle , Humains , Nourrisson , Mâle , Adulte d'âge moyen , Infections à Caliciviridae/épidémiologie , Épidémies de maladies , Gastroentérite/épidémiologie , Norovirus/isolement et purification , Maladie aigüe , Infections à Caliciviridae/transmission , Chili/épidémiologie , Fèces/virologie , Gastroentérite/virologieRÉSUMÉ
OBJETIVO: A cannabis continua sendo a substância ilegal mais amplamente utilizada na maioria dos países desenvolvidos. Seu potencial aditivo foi estabelecido e a necessidade de intervenções em problemas relacionados à cannabis se tornou clara. Este artigo faz uma revisão sobre as pesquisas que avaliam os tratamentos potenciais para transtornos por uso de cannabis. MÉTODO: Uma busca nos bancos de dados de publicações identificou os estudos e revisões na literatura científica sobre as intervenções psicossociais e farmacológicas nos transtornos por uso de cannabis. RESULTADOS: Para adultos, as intervenções com base comportamental geram efeitos positivos significativos na abstinência e nas reduções no uso de cannabis. Em adolescentes, tratamentos similares e intervenções com base na família demonstraram eficácia. Entre os estudos, os índices de resposta parecem ser modestos mesmo com os mais potentes tratamentos psicossociais. As avaliações das abordagens farmacológicas para os transtornos por uso de cannabis têm ainda que fornecer dados sobre a eficácia clínica de qualquer medicação específica. Enfoques baseados em agonistas e antagonistas parecem ser os mais promissores. Os avanços na compreensão da neurobiologia do sistema canabinoide são fonte de otimismo no sentido de que a síntese de compostos que alteram o funcionamento do sítio receptor CB1 possa produzir medicações promissoras. CONCLUSÃO: As pesquisas clínicas identificaram tratamentos psicossociais eficazes, mas ainda não produziram farmacoterapias eficazes. Muitos estudos ainda têm que ser feitos para aumentar a potência e o acesso às intervenções para aqueles que buscam o tratamento para transtornos por uso de cannabis.
OBJECTIVE: Cannabis remains the most widely used illicit substance in most developed countries. Its addictive potential has been established and the need for interventions for cannabis-related problems has become apparent. This article provides a review of the research evaluating potential treatments for cannabis use disorders. METHOD: A search of publication databases identified research studies and reviews of the scientific literature on psychosocial and pharmacological interventions for cannabis use disorders. RESULTS: For adults, behaviorally-based interventions engender significant positive effects on abstinence and reductions in cannabis use. With adolescents, similar treatments and family-based interventions have demonstrated efficacy. Across studies, response rates appear modest even with the most potent psychosocial treatments. Evaluations of pharmacological approaches to cannabis use disorders have yet to provide clinical efficacy data for any specific medication. Agonist and antagonist approaches appear to offer the most promise. Advances in understanding of the neurobiology of the cannabinoid system provide optimism that the synthesis of compounds that alter CB1 receptor site functioning may produce promising medications. CONCLUSION: Clinical research has identified effective psychosocial treatments, but has yet to yield effective pharmacotherapies. Much work remains to enhance the potency of and access to interventions for those seeking treatment for cannabis use disorders.
Sujet(s)
Adolescent , Adulte , Humains , Abus de marijuana/thérapie , Psychothérapie/méthodes , Psychoanaleptiques/usage thérapeutique , Essais cliniques comme sujet , Syndrome de sevrage/traitement médicamenteuxRÉSUMÉ
The experience of a group of 9 doctors and 6 nurses, most of them younger than 30years of age, whom were part of the several volunteer groups directed towards the most damaged earthquake regions, is described. The team had to overcome a number of intense personal emotions related with the magnitude of the destruction, especially in the "adobe"-constructed houses and villages, in order to provide useful medical support. Moving out of the hospital setting, reaching out to the community in schools and emergency posts proved to be important in rural communities. An appropriate coordination of the volunteer groups, with the simultaneous action of municipal and state health authorities, together with well-guided leadership, was critical for an effective response in the larger city of Talcahuano /Hualpén. Within the second week of the aftermath, acute respiratory and intestinal infections were the most common medical complaints together with intense -in many cases severe- emotional distress associated mostly with fear to after shakes ("replicas"), tsunami, and social unrest. The severe earthquake that struck Chile has left many lessons for the future that will need to be analyzed seriously and with the conviction that effective and timely prevention of catastrophic aftermath consequences, although costly, must be a key element of the country's development plan. More importantly, the hundreds if not thousands of volunteers from a variety of health related professions that were moved by the scenes of suffering, and whom responded to individual or group initiatives, allow to foresee that the nation has the moral stamina required to overcome the tragedy and become a better society.
Sujet(s)
Adulte , Femelle , Humains , Mâle , Tremblements de terre , Émotions , Coopération/organisation et administration , Bénévoles/psychologie , Chili , Bénévoles/organisation et administrationRÉSUMÉ
The human bocavirus (HBoV), virus of the Parvoviridae family, discovered by molecular methods in 2005,has been reported in respiratory samples, stool, urine and blood, both in children and adults. Prevalence ratesrange from 0.8% in fecal samples of individuals with acute diarrhea, up to 19% in respiratory samples and blood.HBoV has been detected in up to 43% of nasopharyngeal samples in asymptomatic children. In Chile, HBoV wasdetected in 24.2% of nasopharyngeal swabs in children under 5 years of age with respiratory symptoms of which74% had coinfection with other viruses. In asymptomatic children under 5 years of age, 37.5% of NP sampleswere positive for HBoV. We discuss the role of HBoV as a causal agent of respiratory and/or enteric disease inlight of the high rates of coinfection and asymptomatic infections.
Sujet(s)
Adulte , Enfant , Enfant d'âge préscolaire , Humains , Bocavirus/isolement et purification , Maladies gastro-intestinales/virologie , Infections à Parvoviridae/virologie , Infections de l'appareil respiratoire/virologie , Chili , SaisonsSujet(s)
Humains , Pharmacologie clinique/éthique , Recherche biomédicale/éthique , Bioéthique , ChiliRÉSUMÉ
En este trabajo se resume el concepto de Burnout expuesto por Freudenberger en 1974 y se revisan las diversas propuestas etiopatogénicas psicoanalíticas, en particular las de Cooper. Se propone una definición del concepto desde el vértice del burnout como pérdida de la pasión, desde su descripción en Bion. Se ilustra con una viñeta clínica de supervisión y se propone una modalidad de ésta que permite abordar situaciones en las cuales se sospecha la presencia de Burnout del analista.
In this paper the author summarizes the concept of Burnout, described by Freudenberger in 1974. Several different psychoanalytic ethiopatogenic theories particulary, Arnold Cooper's, are considered. The definition suggested by the author proposes Burnout as a consequence of the loss of passion, as described by Bion. This is illustrated with clinical material from a supervision, a modality of which is proposed when there might be a Burnout syndrome.
Sujet(s)
Humains , Mâle , Adulte , Épuisement professionnel , PsychanalyseRÉSUMÉ
The article briefly reviews the epidemiology of human papillomavirus (HPV) infection and associated diseases in the world and in Chile and the scientific information of the licensed HPV vaccines: Gardasil® and Cervarix®. Considering the available information, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases, summarizes its conclusions and makes recommendations for vaccination against HPV in Chile.
El artículo revisa brevemente la epidemiología de las infecciones por virus papiloma humano (VPH) y las enfermedades asociadas, tanto en el mundo como en Chile y la información científica de las vacunas contra VPH licenciadas: Gardasil® y Cervarix®. Considerando la información disponible, el Comité Consultivo de Inmunizaciones de la Sociedad Chilena de Infectología, resume sus conclusiones y hace sus recomendaciones para la vacunación contra VPH en Chile.
Sujet(s)
Adolescent , Adulte , Femelle , Humains , Adulte d'âge moyen , Jeune adulte , Comités consultatifs , Alphapapillomavirus/immunologie , Vaccins contre les papillomavirus , Infections à papillomavirus/prévention et contrôle , Chili/épidémiologie , Infections à papillomavirus/épidémiologie , Vaccins contre les papillomavirus/effets indésirables , Vaccins contre les papillomavirus/immunologie , Sociétés médicales , Jeune adulteRÉSUMÉ
A sentinel-based outpatient and inpatient surveillance for rotavirus infection has been implemented in Chile. Aim: Update the impact of rotavirus infections in Chile. Methods: Ambulatory surveillance is performed in 14 centers from 8 Regions and hospital-based surveillance in 8 hospitals from three Regions (V, VIII and Metropolitan). Results: In 2007, 339 stool samples that represented 9.3 percent of all outpatient cases were studied of which 15 percent were rotavirus positive. A total of 2.074 children younger than 5 years of age were hospitalized representing 9 percent of all hospitalizations for this age group. Rotavirus was detected in 13.6 percent of these cases. Conclusions: In the current epidemiological situation, rotavirus surveillance needs to be sustained with increased efforts to detect cases in order to avoid underreporting. Serotype/genotype surveillance of rotavirus strains needs to be included in the near future.
En Chile, se realiza la vigilancia de gastroenteritis causadas por rotavirus en niños bajo 5 años a través de centros centinelas ambulatorios y hospitalarios. Objetivo: Conocer la epidemiología de las diarreas por rotavirus y evaluar la carga de morbi-mortalidad. Método: La vigilancia ambulatoria se desarrolla en 14 centros de 8 regiones y la vigilancia hospitalaria se lleva a cabo en 8 hospitales pediátricos de las regiones Vª, VIIIªy RM. Resultados: En 2007, 9,3 por ciento de las consultas por diarrea fue estudiada (339), detectándose rotavirus en 15 por ciento de ellas. Se hospitalizaron por diarrea, 2.074 casos, 9 por ciento del total de las hospitalizaciones en este grupo etario. De estas, 13,6 por ciento fueron por rotavirus. Conclusiones: Dada la situación epidemiológica actual, es importante mantener la vigilancia, ampliar la pesquisa de los casos, aplicar el protocolo de vigilancia establecido y determinar el serotipo/genotipo circulante en el país.
Sujet(s)
Enfant d'âge préscolaire , Femelle , Humains , Nourrisson , Mâle , Gastroentérite/épidémiologie , Gastroentérite/virologie , Infections à rotavirus/épidémiologie , Surveillance sentinelle , Maladie aigüe , Chili/épidémiologie , Diarrhée/épidémiologie , Diarrhée/microbiologie , IncidenceRÉSUMÉ
Molecular, clinical and epidemiolagical studies have established beyond doubt that human papiloma viruses (HPV) cause cervical cancer. The virus is also associated with genital warts and other less common cancers in oropharynx, vulva, vagina and penis. Worldwide, VPH genotypes 16 and 18 are the most common high risk genotypes, detected in near 70 percent of women with cervical cáncer. The discovery of a cause-effect relationship between several carcinogenic microorganisms and cancer open avenues for new diagnostic, treatment and prevention strategies. In this issue of Revista Médica de Chile, two papers on HPV are presented. Guzman and colleagues demonstrate that HPV can be detected in 66 percent to 77 percent of healthy male adolescents by polymerase chain reaction and that positivity depends on the site of the penis that is sampled. These results support the role of male to female transmission of high risk HPVs in Chile and should lead to even more active educational campaigns. The second paper provides recommendations for HPV vaccine use in Chile, generated by the Immunization Advisory Committee of the Chilean Infectious Disease Society. To issue these recommendations, the Committee analyzes the epidemiological information available on HPV infection and cervical cancer in Chile, vaccine safety and effectiveness data, and describes cost-effectiveness studies. Taking into account that universal vaccination is controversial the Committee favors vaccine use in Chile and it's incorporation into a national program. However, there is an indication that the country requires the implementation of an integrated surveillance approach including cross matching of data obtained from HPV genotype surveillance, monitoring of vaccination coverage, and surveillance of cervical cáncer The final decision of universal vaccine use in Chile should be based on a through analysis of information.
Sujet(s)
Adolescent , Femelle , Humains , Mâle , Alphapapillomavirus/génétique , Infections à papillomavirus/virologie , Vaccins contre les papillomavirus , Tumeurs du col de l'utérus/virologie , Alphapapillomavirus/immunologie , Chili/épidémiologie , Infections à papillomavirus/épidémiologie , Infections à papillomavirus/prévention et contrôle , Tumeurs du col de l'utérus/épidémiologie , Tumeurs du col de l'utérus/prévention et contrôleRÉSUMÉ
This article briefly reviews the epidemiology of human papillomavirus (HPV) infection and associated diseases globally and in Chile, and the scientific ínformatíon of the licensed HPV vaccines: Gardasil® and Cervarix®. Considering the available information, the Advisory Committee on Immunizations of the Chilean Society of Infectious Diseases recommends vaccination of teenage girls, ideally before initiating sexual actívíty, Le. approximately at the age of 12 to 13 years and vaccination of women of any age if they have not started sexual activity. If women are vaccinated after initiating sexual activity, they should be informed of the lower efficacy of immunization if HPV infection has occurred. Education on responsible sexuality and sexually transmitted diseases should be maintained as a priority. Vaccination should be highly considered for inclusion in the National Immunization Program.
Sujet(s)
Adolescent , Adulte , Enfant , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , Comités consultatifs , Immunisation , Papillomaviridae , Infections à papillomavirus/prévention et contrôle , Vaccins contre les papillomavirus , Chili/épidémiologie , Papillomaviridae/classification , Papillomaviridae/génétique , Papillomaviridae/immunologie , Infections à papillomavirus/épidémiologie , Infections à papillomavirus/virologie , Vaccins contre les papillomavirus/effets indésirables , Vaccins contre les papillomavirus/immunologie , Sociétés médicales , Jeune adulteRÉSUMÉ
El timerosal es un derivado del mercurio utilizado desde 1930 como preservante de vacunas. En las últimas décadas ha sido cuestionada su seguridad, especialmente por la posibilidad de toxicidad neurológica. La revisión de varios estudios realizados en niños que recibieron vacunas que contienen timerosal y la posición de organismos de expertos internacionales en relación al uso de este compuesto en vacunas, permite al Comité Consultivo de Inmunizaciones concluir que no existe evidencia de eventos adversos en lactantes o niños por exposición al timerosal contenido en vacunas rutinarias y, por lo tanto, no habría razón para modificar las actuales prácticas de inmunización en Chile.
Thimerosal is a mercury derivative included in vaccines since 1930 with the aim to prevent microbial contamination. During the last decades, the use of thimerosal has been questioned, specifically because of a potential association with neurotoxicity. After a thorough review of published studies on pediatric use of thimerosal-containing vaccines, and of position papers from international expert groups, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases concludes that there is no solid evidence of adverse events associated with the use of thimerosal containing vaccines in infants and children. Therefore, a change in current vaccine practices refererred to thimerosal-containing vaccines is not justified in Chile.
Sujet(s)
Enfant , Humains , Nourrisson , Conservateurs pharmaceutiques , Thiomersal , Vaccins/composition chimique , Trouble autistique/induit chimiquement , Chili , Conservateurs pharmaceutiques/effets indésirables , Normes de référence , Sociétés médicales , Thiomersal/effets indésirables , Vaccins/effets indésirablesRÉSUMÉ
In the present study, we have applied a novel approach to generate specific digoxigenin- and biotin-labeled RNA probes to detect Feline Immunodeficiency Virus (FIV) gag gene in the FIV-infected feline T-lymphoblastoid cell line (MYA-1). This involved cloning of the FIV gag gene into a PCR Script vector containing both T3 and T7 promoters, followed by amplification of the insert and the two promoter sequences, using specific primer sequences. The FIV RNA probes were more sensitive than FIV DNA probes. This approach should make RNA in situ hybridization more accessible for use in routine diagnosis.
Sujet(s)
Animaux , Biotine , Chats , Lignée cellulaire tumorale , Sondes d'ADN , Digoxigénine , Gènes viraux , Gènes gag , Vecteurs génétiques , Virus de l'immunodéficience féline/classification , Hybridation in situ , Lymphocytes/cytologie , Réaction de polymérisation en chaîne , Régions promotrices (génétique) , Sondes d'ARN , Coloration et marquage , Virologie/méthodesRÉSUMÉ
Se relatan aspectos clínicos del análisis de ocho años de duración de un paciente esquizoide con crisis de pánico. Se hace una revisión del concepto de Steiner de Refugios Psíquicos y su relación con la severidad del Superyó y de los aspectos biológicos involucrados en las crisis de pánico, para plantear finalmente una integración de ambos vértices y algunas reflexiones en torno al proceso analítico desde las ideas de Bion.
Sujet(s)
Adulte , Mâle , Humains , Narcissisme , Panique , Psychanalyse/classification , Psychanalyse/méthodes , Trouble panique/psychologie , Trouble de la personnalité de type schizoïde/psychologieRÉSUMÉ
Rotavirus es la primera causa de diarrea aguda grave en niños bajo 3 años de edad en el mundo. Esta infección es responsable de 25 millones de consultas, 2 millones de hospitalizaciones y 440.000 muertes por año en niños con menos de 5 años. El desarrollo de vacunas anti-rotavirus ha sido un camino largo y tortuoso marcado por la abrupta caída de Rotashield® en 1999 debido a su asociación con invaginación intestinal. Luego de seis años de intensa investigación, el mundo celebra la licencia de dos nuevas vacunas que, a pesar de ser diferentes en su formulación y forma de administración, han demostrado ser seguras y no asociadas a invaginación intestinal, en estudios de Fase III de gran magnitud, que enrolaron más de 60.000 niños. Estas dos vacunas, Rotarix® de Glaxo SmithKline Biologicals y Rotateq® de Merck Sharp & Dohme son altamente eficaces contra diarrea grave causada por rotavirus de los serotipos más prevalentes en el mundo. La incorporación de estas vacunas, más temprano que tarde, especialmente en los países más pobres del mundo, requerirá de un esfuerzo conjunto de los gobiernos, laboratorios productores, organismos internacionales y no gubernamentales y fundaciones de beneficencia.
Sujet(s)
Humains , Enfant , Efficacité en Santé Publique , Infections à rotavirus/immunologie , Infections à rotavirus/prévention et contrôle , Vaccins anti-rotavirus/immunologie , Vaccins anti-rotavirus/usage thérapeutique , Diarrhée/virologie , Maladies gastro-intestinales/virologie , Infections à rotavirus/génétique , Intussusception/induit chimiquement , Vaccins anti-rotavirus/effets indésirables , Vaccins anti-rotavirus/génétique , Vaccins antiviraux/effets indésirablesRÉSUMÉ
Background. Intussusception (IS) is a potentially severe disease that affects an undetermined number of Chilean infants. The withdrawal of a rotavirus vaccine in 1999 due to its association with IS, highlighted the need for updated information on IS worldwide including Chile, before introduction of new vaccines. Aim: To estimate the incidence and to describe the epidemiology and clinical presentation of IS in the Metropolitan Area of Chile. Material and methods. IS cases occurring between 1996 and 2001 in the seven public pediatric hospitals and in six private clinics (during 2000 and 2001) were identified. Incidence rates were calculated using updated population estimates. A systematic review of the medical charts of IS cases occurring in the public hospitals for 2000-2001 was performed. Results. IS incidence rates for the Public Sector ranged from 32 to 39 per 100.000 children < 2 years of age. These figures did not vary significantly among the different Health Care Services, nor after inclusion of the private clinics. IS was more common in males (66%) and infants younger than 12 months (83%), with 67% of cases occurring between 3 and 8 months of age. The most common presenting symptoms were abdominal pain (90%), vomiting (86%), and rectal bleeding (75%). Ileocolic IS predominated (83%) and surgical correction was the preferred treatment (81%). No death occurred in this series. Conclusions: IS incidence rates were intermediate compared to other series, stable over time, and similar between the public and private sector. Clinical characteristics were similar to those previously reported with a disproportionately high use of surgical correction over enema, currently considered the preferred treatment option. (Rev MÚd Chile 2004; 132: 565-72).
Sujet(s)
Humains , Mâle , Femelle , Nourrisson , Intussusception/diagnostic , Intussusception/épidémiologie , Chili/épidémiologie , Maladies intestinales , Incidence , Intussusception/chirurgie , Intussusception/thérapieSujet(s)
Humains , Mâle , Adulte , Psychanalyse/classification , Dossiers médicaux/classification , Rêves/psychologieRÉSUMÉ
Background: Human calciviruses (HuCVs) cause diarrhea outbreaks associated with consumption of contaminated food and water. Seroepidemiological studies in developing countries, suggest that HuCVs can cause acute gastroenteritis in children. Aim: To study the presence of Norwalk (NV) and Mexico (MX) virus, two HuCVs, in stools of Chilean children from different settings. Subjects and methods: ELISA tests for NV and MX were performed in 677 stool samples for children aged 0 to 132 years old, with acute diarrhea occurring in day care centers or consulting in outpatient clinics or emergency rooms. We also studied eight samples from children involved in a diarrhea outbreak that occurred in a rural community in 1992. A subset of samples was tested with polymerase chain reactions using different primers. Results: Only one sample from a child with acute diarrhea occurring in a day care center was positive for HuCV by polymerase chain reaction. Three samples from the outbreak were positive by the latter method and by ELISA. The HuCV obtained from the day care center was genetically different from other known HuCV. Conclusions: Despite the high seroprevalence, NV and MX viruses were detected in a very low proportion of Chilean children stools